Expert witness to support pharma litigation process
Challenge:
A major global law firm required an expert witness to support a litigation process between it client and another Big Pharma company.
Solution:
Alacrita provided a suitable expert who had deep experience in the technology domain, the stage of development of the asset in question and in the practices of licensing and commercializing the particular type of product. The expert worked under the direction of the law firm and its client until the process reached its conclusion.
Related Case Studies
Explore similar engagements and see how we've helped other clients achieve their goals.
Due Diligence
Pre-Due Diligence Assessment of First-in-Class Allergy Therapeutic
Challenge: A pharmaceutical company seeking new assets requested a pre-due diligence assessment of a European biotech developing a first-in-class compound for treating allergic...
Due Diligence
Strategic Partnership Assessment of Autoimmune Drug Development Program
Challenge: A pharmaceutical client asked Alacrita to assess a early-stage biotech company developing an orally-available agent for treating various autoimmune conditions. The...
Due Diligence
Pre-Due Diligence Assessment of a Women's Health Biotech Partnership
Challenge: A pharmaceutical company was actively searching for strategic partnering opportunities to expand its pipeline and had commissioned Alacrita to conduct a comprehensive...
Due Diligence
Due Diligence of an Academic Adenovirus Gene-Therapy Program
Challenge: A pharmaceutical company with an established gene-therapy franchise wanted to expand its oncology pipeline through external licensing. Among several options, the deal...
Interested in Learning More?
Contact us to discuss how we can support your project with similar expertise.